1. Home
  2. PRTC vs SHYF Comparison

PRTC vs SHYF Comparison

Compare PRTC & SHYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • SHYF
  • Stock Information
  • Founded
  • PRTC 2015
  • SHYF 1975
  • Country
  • PRTC United States
  • SHYF United States
  • Employees
  • PRTC N/A
  • SHYF N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • SHYF Auto Manufacturing
  • Sector
  • PRTC Health Care
  • SHYF Consumer Discretionary
  • Exchange
  • PRTC Nasdaq
  • SHYF Nasdaq
  • Market Cap
  • PRTC 432.3M
  • SHYF 428.3M
  • IPO Year
  • PRTC N/A
  • SHYF N/A
  • Fundamental
  • Price
  • PRTC $18.50
  • SHYF $10.49
  • Analyst Decision
  • PRTC Buy
  • SHYF Strong Buy
  • Analyst Count
  • PRTC 1
  • SHYF 2
  • Target Price
  • PRTC $45.00
  • SHYF $15.50
  • AVG Volume (30 Days)
  • PRTC 3.2K
  • SHYF 265.2K
  • Earning Date
  • PRTC 04-30-2025
  • SHYF 07-24-2025
  • Dividend Yield
  • PRTC N/A
  • SHYF 1.90%
  • EPS Growth
  • PRTC N/A
  • SHYF 744.40
  • EPS
  • PRTC 0.21
  • SHYF 0.01
  • Revenue
  • PRTC $4,828,000.00
  • SHYF $792,886,000.00
  • Revenue This Year
  • PRTC $35.98
  • SHYF $14.16
  • Revenue Next Year
  • PRTC $115.38
  • SHYF $9.78
  • P/E Ratio
  • PRTC $8.24
  • SHYF $838.39
  • Revenue Growth
  • PRTC 44.98
  • SHYF N/A
  • 52 Week Low
  • PRTC $13.30
  • SHYF $6.82
  • 52 Week High
  • PRTC $32.98
  • SHYF $17.56
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 58.17
  • SHYF 65.46
  • Support Level
  • PRTC $17.80
  • SHYF $9.02
  • Resistance Level
  • PRTC $19.17
  • SHYF $10.73
  • Average True Range (ATR)
  • PRTC 0.48
  • SHYF 0.43
  • MACD
  • PRTC 0.13
  • SHYF 0.07
  • Stochastic Oscillator
  • PRTC 74.72
  • SHYF 85.96

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

About SHYF The Shyft Group Inc.

The Shyft Group Inc is engaged in specialty vehicle manufacturing and assembly for commercial vehicles (including last-mile delivery, specialty service, and vocation-specific upfit segments) and recreational vehicle industries. Its products include walk-in vans, truck bodies, cargo vans, and pick-up truck upfits used in e-commerce/parcel delivery, upfit equipment used in the mobile retail and utility trades, as well as luxury Class A diesel motorhome custom chassis and contract manufacturing and assembly services. It also supplies replacement parts and offers repair, maintenance, field service, and refurbishment services for the vehicles that the company manufactures.

Share on Social Networks: